OPTO: Invest Smarter
OPTO – Smart Investing, On Autopilot Invest like a pro without the fees**. OPTO lets you design your own stock index while automated rebalancing keeps
About this Tool
OPTO – Smart Investing, On Autopilot
Invest like a pro without the fees**. OPTO lets you design your own stock index while automated rebalancing keeps
Invest like a pro without the fees**. OPTO lets you design your own stock index while automated rebalancing keeps your portfolio aligned with your strategy—no manual adjustments needed.
DESIGN YOUR OWN INDEX
Build your own Folio from multiple stocks, allocated using a professional strategy—automatically rebalanced quarterly.
ZERO FEES
Creating and holding an OPTO account is free*. Enjoy zero fees when buying or selling stocks, ETFs, or Folios—so you can in
Pros & Cons
✓ Pros
- ✓Unlimited free transfers and withdrawals
- ✓$100 minimum per Folio
- ✓No hidden fees
- ✓Workflow automation
✗ Cons
- ✗No native Android app
- ✗Requires a paid subscription for full access
Key Features
Commission-free trading
Unlimited free transfers and withdrawals
$100 minimum per Folio
No hidden fees
📋 Scripts & Prompts for OPTO: Invest Smarter
Copy these AI-powered scripts to get maximum value from this tool. Sign up free to copy.
🔌 MCP Servers for OPTO: Invest Smarter
Connect these MCP servers to give Claude, Cursor & Cline superpowers with this tool. Sign up free to copy install commands.
🤖 AI Agents for OPTO: Invest Smarter
Pre-built automation agents that work with this tool — import in one click. Sign up free to access.
Similar Finance & Trading Tools
Tags
Frequently Asked Questions
OPTO: Invest Smarter is available as $300. Visit the tool's website for the latest pricing details and plan options.
Visit the OPTO: Invest Smarter website to check whether a free tier or free trial is available.
OPTO: Invest Smarter is available on Api, iOS. Check the official website for the latest platform support.
Many tools offer free trials to let you test before subscribing. Check the OPTO: Invest Smarter website for current trial availability and duration.